ClinicalTrials.gg
Not yet recruitingNCT07423884Updated Apr 13, 2026

Effect of a Low-Calorie MCT-Rich Traditional Minangkabau Diet on Obese Individuals

An interventional study of Low-Calorie Diet Rich in Medium-Chain Triglycerides (MCTs) Based on Traditional Minangkabau Foods in Metabolically Unhealty Obese, Dyslipidemia and Diabetes (DM), sponsored by Andalas University. Not yet recruiting at 1 site in Indonesia. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-13.

Sponsored by Andalas University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by May 2026, 6 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to investigate the effect of a low-calorie diet rich in medium-chain triglycerides (MCTs) based on traditional Minangkabau foods on metabolic biomarkers in individuals with obesity. The traditional Minangkabau foods used in this study consist primarily of coconut milk-based dishes, which contain coconut oil as a natural source of MCTs. The metabolic biomarkers assessed include body mass index (BMI), waist circumference, systolic and diastolic blood pressure, body fat percentage, fasting blood glucose levels, lipid profile, leptin concentrations, and DNA methylation of the leptin gene promoter. Based on these metabolic biomarker measurements, participants will be classified into metabolic obesity phenotypes, namely metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUHO). The researchers hypothesize that the provision of a low-calorie, MCT-rich diet based on traditional Minangkabau foods will have a significant effect on metabolic biomarkers and metabolic status in individuals with obesity.

Read the detailed description

This study was conducted within the Faculty of Medicine and the Faculty of Public Health at Andalas University, Padang, and received ethical approval from the Research Ethics Committee of the Faculty of Medicine, Andalas University. The study population consisted of educational staff with a body mass index (BMI) greater than 25 kg/m². Study participants were educational staff who agreed to participate and provided written informed consent. A total of 40 participants were included in the study, comprising 20 participants in the intervention group and 20 participants in the control group.

The study was conducted over a period of 12 weeks (90 days). One week prior to the intervention, dietary intake was assessed using the 24-hour food recall method. Anthropometric measurements were performed using calibrated instruments by trained personnel.

Participants in both the intervention and control groups underwent a one-week pre-intervention period (baseline period, from day -6 to day 0), during which they were instructed not to consume any supplements. Anthropometric measurements, blood pressure, body fat percentage, fasting blood glucose levels, lipid profile, leptin concentrations, and DNA methylation of the leptin gene promoter were assessed on day 0 and day 90.

Dietary intake data obtained from the 24-hour food recall interviews were analyzed using the NutriSurvey 2005 software. The dietary intervention was designed to provide an energy deficit of 500-600 kcal compared with participants' habitual daily intake. The diet was based on traditional Minangkabau foods.

Participants in the intervention group were provided with daily menu plans for breakfast, lunch, and dinner. The dietary intervention was prepared independently by participants in accordance with the dietary guidelines and menus provided. In contrast, the control group followed a standard nutritionally balanced diet according to individual requirements. Participants were instructed to record their daily food intake in a food diary, which was collected and evaluated twice weekly (on weekdays and weekends). In addition, the research team monitored and motivated all participants through WhatsApp groups. Data analysis was performed using SPSS software.

02

Conditions studied

  • Metabolically Unhealty Obese
  • Dyslipidemia
  • Diabetes (DM)
  • Resistance, Insulin
  • Obesity

Keywords

  • Low-calorie diet rich in medium-chain triglycerides
  • Traditional Minangkabau foods
  • Coconut oil
  • Metabolic biomarkers
  • Anthropometric parameters
03

In context

Dyslipidemias

1,251 studies on the registry are indexed under Dyslipidemias; 178 are open to participants now.

This study's planned enrollment of 40 is below the median of 100 across 988 interventional studies indexed under Dyslipidemias.

Browse Dyslipidemias studies →

Lead sponsor

Andalas University is the lead sponsor of 7 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Administrative staff of the Faculty of Medicine and the Faculty of Public Health, Andalas University, Padang, with obesity defined as a (BMI) ≥ 25 kg/m².
  • Willing to participate in the study by providing written .
  • Participants with obesity classified as Metabolically Unhealthy Obese (MUHO)

Exclusion criteria

Exclusion Criteria:

  • Did not come and could not be found at the time of research data collection
  • Unable to follow the dietary arrangements as set
  • Taking anti-diabetic or anti-lipid drugs
  • Use of or hormonal drugs
  • In the treatment of radiotherapy or chemotherapyi
  • Participants with obesity classified as Metabolically Healthy Obese (MHO)
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Intervention group (low-calorie diet rich in medium-chain triglycerides [MCTs] based on traditiona

    Low-Calorie Diet Rich in Medium-Chain Triglycerides (MCTs) Based on Traditional Minangkabau Foods Participants in the intervention group received a nutritionally balanced low-calorie diet rich in medium-chain triglycerides (MCTs) derived from traditional Minangkabau foods. The dietary intervention was designed to provide an energy deficit of 500-600 kcal compared with participants' habitual daily intake. Assessments were conducted before and after the intervention period.

    Other: Low-Calorie Diet Rich in Medium-Chain Triglycerides (MCTs) Based on Traditional Minangkabau Foods

  • No intervention
    Control group (standard nutritionally balanced diet)

    Standard Nutritionally Balanced Diet Participants in the control group received a standard nutritionally balanced diet without specific emphasis on MCT content. This diet was not designed to induce an energy deficit and was instead tailored to participants' usual daily dietary habits and energy requirements. Assessments were conducted before and after the study period.

Interventions

  • OtherLow-Calorie Diet Rich in Medium-Chain Triglycerides (MCTs) Based on Traditional Minangkabau Foods

    Participants in the intervention group received a nutritionally balanced low-calorie diet rich in medium-chain triglycerides (MCTs) derived from traditional Minangkabau foods. The dietary intervention was designed to provide an energy deficit of 500-600 kcal compared with participants' habitual daily intake. Assessments were conducted before and after the intervention period.

06

What researchers measure

Primary outcomes

  1. Change from baseline in body mass index (BMI).

    BMI is calculated as body weight in kilograms divided by the square of height in meters (kg/m²).

    Time frame: After 12 weeks

  2. Change from baseline in waist circumference.

    Waist circumference is measured around the abdomen at the level of the umbilicus.

    Time frame: After 12 weeks

  3. Change from baseline in body fat percentage

    Body fat percentage is assessed using bioelectrical impedance analysis (BIA).

    Time frame: After 12 weeks

  4. Change from baseline in systolic and diastolic blood pressure

    Blood pressure is measured using a digital tensimeter.

    Time frame: After 12 weeks

  5. Change from baseline in fasting blood glucose levels.

    Fasting blood glucose levels are measured using a clinical chemistry analyzer.

    Time frame: After 12 weeks

  6. Change from baseline in lipid profile.

    The lipid profile includes total cholesterol, triglycerides, high-density lipoprotein (HDL) cholesterol, and low-density lipoprotein (LDL) cholesterol. Measurements are performed using a clinical chemistry analyzer (photometer).

    Time frame: After 12 weeks

  7. Change from baseline in serum leptin.

    Serum leptin concentrations are measured using appropriate laboratory methods (ELISA).

    Time frame: After 12 weeks

  8. Change from baseline in DNA methylation of the leptin gene promoter.

    DNA methylation status of the leptin gene promoter is assessed using MSP (Methylation-Specific PCR).

    Time frame: After 12 weeks

Secondary outcomes

  1. Change in metabolic status.

    Metabolic status is classified into Metabolically Healthy Obesity (MHO) and Metabolically Unhealthy Obesity (MUHO) based on the number of metabolic abnormalities present. * MHO is defined as the presence of 0-1 metabolic abnormality. * MUHO is defined as the presence of ≥2 metabolic abnormalities. These metabolic abnormalities included elevated fasting blood glucose levels, increased blood pressure, enlarged waist circumference, elevated triglyceride levels, and reduced high-density lipoprotein (HDL) cholesterol levels.

    Time frame: After 12 weeks

07

Study locations

1 site
  • Prof. Nur Indrawaty Lipoeto
    Padang, West Sumatera, Indonesia
08

References and documents

Publications

  • Lipoeto, N.I., Elliyanti, A. and Febri, D.S. (2025) 'The Effect of A Low-Calorie Balanced Nutrition Diet Based on Minang Cuisine in Obese Patients', 10(February), pp. 26-34.
  • Lipoeto NI, Agus Z, Oenzil F, Wahlqvist M, Wattanapenpaiboon N. Dietary intake and the risk of coronary heart disease among the coconut-consuming Minangkabau in West Sumatra, Indonesia. Asia Pac J Clin Nutr. 2004;13(4):377-84. PubMed 15563444 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Apr 2026; primary completion for May 2026, 1 month later.

Of 194 non-industry interventional studies with no phase under Dyslipidemias, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 42. This study's planned 1 month is below that.

Counting every sponsor, half of 205 studies reached it within 16 months; a quarter within 8 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 14, 2026
First posted
Feb 20, 2026
StartEst.
Apr 2026
Primary completionEst.
May 2026
CompletionEst.
Jul 2026
Last update
Apr 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07423884
Lead sponsor
Andalas University
Responsible party
Nola Vita Sari (Bachelor of Nutrition, Andalas University) — Principal investigator
First posted
Feb 20, 2026
Start date
Apr 2026 (estimated)
Primary completion
May 2026 (estimated)
Completion
Jul 2026 (estimated)
Last update
Apr 13, 2026

Study contacts

Nur Indrawaty Lipoeto, Professor
Contact
indralipoeto@med.unand.ac.id
+6281275950763
Nola Vita Sari
Contact
2430312022_nola@student.unand.ac.id
+62823 8911-0304
Nur Indrawaty Lipoeto, Professor
principal investigator · Universitas Andalas

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion